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Severe arrhythmia due to hyp
from diuretic substances
Arritmia cardiaca grave por hipopo
sustancias diuréticas
Dear Editor,
This was a case of a 25-year-old woman with no known aller-
gies or relevant medical history and no toxic habits. She is an
attorney and drinks 500–750ml of beverages containing tau-
rine and 1 l of caffeinated soda per day due to stress. The fol-
lowing details were observed: height 170 cm, weight 58kg and
BMI 20. She was admitted to the hospital for headache
and tachycardia during the last two days after she did some
sports and coinciding with an increase in the consumption
of a beverages containing taurine. She denied chest pain or
dyspnoea. Had no vomiting or diarrhoea and had no change
in diuresis. She did not consume herbal products, drugs,
teas, diuretics, liquorice or alcohol. Physical examine: Con-
scious, oriented, blood pressure 108/86, heart rate 110 beats
per minute. Afebrile. Anodyne cardiopulmonary auscultation.
Rest of the examination was normal. Blood test: normal red cell
count, no elevation of cardiac or hepatic enzymes and coag-
ulation test without alterations; creatinine 1.04mg/dL, urea
31mg/dL, potassium 1.73mEq/L, sodium 134mEq/L, magne-
sium 2.2mg/dL, chloride 85mEq/L, Albumin 4g/dL. Arterial
blood gas: Ph 7.580, PCO2 46mmHg, PO2 86mmHg, bicarbonate
43.1mmol/L. Plasma anion gap (AG): 5.9mEq/L. Urine: chloride
22.2mEq/L, potassium 68.28mEq/L, sodium 210mmol/L, urea
920mg/dL, creatinine 192.72mg/dL, glucose 15mg/dL. Urine
anion gap: 256mEq/L. Plasma osmolality: 278.2mOsm/L.
Urine osmolality: 573.3mOsm/l. Transtubular potassium
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alemia. Inﬂuence
semia. Inﬂuencia de las
gradient: 15. Cortisol at 8 am and aldosterone in supine
position were within the normal range. No alterations in uri-
nary sediment. ECG: sinus rhythm, markedly enlarged QT
(580ms; corrected 700ms); with frequent polymorphic ven-
tricular tachycardia (Fig. 1). An infusion of CLK was initiated
via central line: 80mEq within two hours and maintained with
an infusion of 120mEq/day. After 18h, urine test was: sodium
25.3mEq/L, potassium6.2mEq/L; in serum: sodium142mEq/L,
potassium 2.8mEq/L transtubular potassium gradient: 4.
Venous blood gas: Ph 7.380, PCO2 52mmHg, HCO3 30.8. Blood
test at discharge: sodium 143mEq/L, potassium 4.84mEq/L,
chloride 105m Eq/L, pH 7.380, pCO2 49mmHg, bicarbon-
ate 29mmol/L. Urine: potassium 11.59mmol/L, sodium
89mmol/L, creatinine 266.27mg/dL, urea 642mg/dL. The ECG
was normal. The evolution of ions in the urine suggested
the presence of a diuretic substance that was suspended
at admission. Diagnoses: hypokalaemia due to diuretic sub-
stances: taurine and caffeine, but not being able to rule out
the presence of other diuretics, aggravated by the increase of
insensitive losses and alkalemic state. A Bartter vs Gitelman-
type tubulopathy was ruled out given the evolution of the ions
in urine and the hormonal axis normality. Alteration in heart
conduction due to hypokalaemia.Mixed alkalaemia: Chloride-
resistant metabolic alkalosis due to diuretic substances anderto-Blazquez L, Sanchez-Tomero JA. Arritmia cardiaca grave por
5;35:334–336.
reactive respiratory alkalosis.
Ninety percent of the potassium ﬁltered at glomerular level
is reabsorbed in the proximal tube. The distal tubule, by effect
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tubulopathies (Bartter and Gitelman) may not be distinguish-
able from the intake of diuretics. Hyperaldosteronism and
hypermineralcorticoidism cause hypokalaemia due to their
action on the distal nephron. Potassium is a predominant
intracellular cation. The best marker to assess the renal man-
agement of potassium is TTKG in euvolemia that assesses
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the mineralocorticoid action on the distal nephron: values <4
indicates absence and >7 presence of activity. Blood pressure,
extrarenal losses, acid-base state, urinary ions and urine and
plasma AG have to be assessed. In the presence of metabolic
alkalosis, as in our case, chloride concentration decreases in
order to compensate for the elevation of bicarbonate and the
AG increases in proportion to the alkalosis severity, due to the
lactate and the concentration of more anionic serum proteins.
In turn, the kidney tends to increase the excretion of bicarbon-
ate at proximal and distal tube level where there is a Cl−/HCO3
exchange in the beta-intercalated cells of the collecting tubule.
Serious chloride, potassium or extracellular space depletion
inhibits this exchange. Urine AG is an indicator of urinary
acidiﬁcation. Positive values indicate that renal acidiﬁcation
is intact. Treatment must be oral. The intravenous line is
reserved for serious hypokalaemia (K<2.5mEq/l), arrhythmia,
acute myocardial infarction or digitalisation.1
Some characteristics of the energy drinks diuretic compo-
nents:
Caffeine
Natural xanthine. Energy drinks have levels between 75 and
174mg per serving, others exceed 500mg.2 This stimulates
the central nervous system, cardiovascular system, and cen-
tral respiratory system; it relaxes the smooth bronchialmuscle
and striated muscle, increases acid gastric secretion and renal
blood ﬂuid and has diuretic properties. Many of these effects
are caused by antagonic action on adenosine receptors.3 It
is rapidly distributed through the organism and crosses the
placental and blood–brain barrier. It has hepatic metabolism
(cytochrome P-450). It is clinically used as a respiratory stim-
ulant in newborns with apnoea of prematurity. The adverse
effects include insomnia, agitation, headache and tachycardia
at elevateddoses.4 The changes in bloodpressure response are
not conclusive.5 It can produce dependence syndrome.6
Taurine
Conditionally essential amino acid. Its deﬁcit is associated
with cardiomyopathy, retinal degeneration and failure to
thrive.7 Metabolic actions include: bile acids conjugation,
osmolar regulation, detoxiﬁcation, membranes stabilisation
and modiﬁcation of cellular sodium and calcium levels. It has
positive inotropic action and protects the cardiac membrane
from the adverse effects of hyperglycaemia.7,8 Its renalprotec-
tive effect is caused by its antioxidant action by controlling
the effects generated by TGF-B1 and type I and IV collagen.8
It increases the glomerular ﬁltration rate, reduces sodium
tubular reabsorption, reduces urine protein and inhibits antid-
iuretic hormone production.8,9 Clinically, it has been used in
hypercholesterolaemia, epilepsy, cardiopathy, retinal macular
degeneration, Alzheimer’s disease, cystic ﬁbrosis and hepatic
diseases.10Both of them increase natriuresis increasing the arrival of
sodium at the distal tubule: activating aldosterone and pro-;35(3):328–339
ducing the entry of cellular sodium and the exit of potassium
to the tubular light causing hypokalaemia.
Most of the supplements contained in the energy drinks
have concentrations below the amounts associated with
adverse effects.4 The association of heart conduction alter-
ations is not clear with studies for and against them.11,12 The
combination of these drinks with alcohol may cause arrhyth-
mias in subjects prone to them.13
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